サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
表紙：幹細胞技術および用途の世界市場：2023-2033年
市場調査レポート
商品コード
1379264

幹細胞技術および用途の世界市場：2023-2033年

Stem Cell Technologies and Applications Market Report 2023-2033
出版日: | 発行: Visiongain Reports Ltd. | ページ情報: 英文 337 Pages | 納期: 即日から翌営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: GBPを日本円(税抜)に換算
本日の銀行送金レート: 1GBP=201.04円

ご注意:
Single UserとTeamライセンスは、DRM (デジタル著作権管理システム) 付PDFになります。制限内容は、上記ライセンスの[詳細]アイコンをクリックしてご確認ください。

幹細胞技術および用途の世界市場：2023-2033年
出版日: 2023年11月06日
発行: Visiongain Reports Ltd.
ページ情報: 英文 337 Pages
納期: 即日から翌営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

世界の幹細胞技術および用途の市場規模は、2033年にかけてCAGR 8.7%で成長すると予測されています。

政府支援の拡大が市場成長を牽引

幹細胞のR&Dに対する政府支援の拡大が幹細胞企業の成長を後押ししています。2022年には、この分野で多くの重要な進展が見られました。世界の各国政府は幹細胞研究に多額の投資を行っています。米国国立衛生研究所 (NIH) は2022年に37億米ドルの資金を幹細胞研究に提供しました。幹細胞企業を支援するための新たなプログラムも政府によって導入されつつあります。英国政府は2022年、幹細胞企業による新規治療法の市場導入を支援するため、3,000万ポンド (3,700万米ドル) 相当の新たな基金を設立しました。

幹細胞治療の高コスト性が業界の成長を妨げる

最先端の医療技術である幹細胞治療によって、さまざまな病気や障害が改善される可能性があります。しかし、幹細胞治療にかかる費用の高さは大きな障害の一つです。使用される幹細胞のタイプ、対象疾患、治療センターの場所にもよりますが、今日の幹細胞治療の平均的な費用は5,000ドルから50,000ドルです。

保険が適用されないことも、幹細胞治療の価格を引き上げる理由の一つです。現在、幹細胞治療は実験的治療とみなされているため、保険会社の大半は保険適用外となっています。そのため、患者は治療費の全額を負担することになります。

当レポートでは、世界の幹細胞技術および用途の市場を調査し、市場概要、市場成長への影響因子および市場機会の分析、市場規模の推移・予測、各種区分・地域別の詳細分析、競合情勢、主要企業のプロファイルなどをまとめています。

目次

第1章 レポート概要

第2章 エグゼクティブサマリー

第3章 市場概要

  • 主な調査結果
  • 市場力学
    • 市場促進要因
    • 市場抑制要因
    • 市場機会
  • COVID-19の影響分析
  • ポーター分析
  • PEST分析

第4章 幹細胞技術および用途市場の分析：タイプ別

  • 主要調査結果
  • 市場魅力度指数
  • 市場規模の推移・予測
  • 同種幹細胞療法
  • 自家幹細胞療法

第5章 幹細胞技術および用途市場の分析：細胞由来別

  • 主要調査結果
  • 市場魅力度指数
  • 市場規模の推移・予測
  • 脂肪組織由来MSC
  • 骨髄由来MSC
  • 胎盤/臍帯由来MSC

第6章 幹細胞技術および用途市場の分析：製品別

  • 主要調査結果
  • 市場魅力度指数
  • 市場規模の推移・予測
  • 成人幹細胞
  • ヒト胚性幹細胞
  • 人工多能性幹細胞
  • 微小胚様幹細胞

第7章 幹細胞技術および用途市場の分析：技術別

  • 主要調査結果
  • 市場魅力度指数
  • 市場規模の推移・予測
  • 細胞取得
  • 細胞生成
  • 冷凍保存
  • 増殖・継代培養
  • その他

第8章 幹細胞技術および用途市場の分析：用途別

  • 主要調査結果
  • 市場魅力度指数
  • 市場規模の推移・予測
  • 癌
  • 心血管疾患
  • 神経学的障害
  • 炎症性疾患・自己免疫疾患
  • 筋骨格系疾患
  • その他

第9章 幹細胞技術および用途市場の分析：エンドユーザー別

  • 主要調査結果
  • 市場魅力度指数
  • 市場規模の推移・予測
  • 製薬・バイオテクノロジー企業
  • 病院・細胞バンク
  • 学術研究機関

第10章 幹細胞技術および用途市場の分析：地域別

  • 主要調査結果
  • 市場規模の推移・予測

第11章 北米の幹細胞技術および用途市場の分析

第12章 欧州の幹細胞技術および用途市場の分析

第13章 アジア太平洋の幹細胞技術および用途市場の分析

第14章 ラテンアメリカの幹細胞技術および用途市場の分析

第15章 中東・アフリカの幹細胞技術および用途市場の分析

第16章 企業プロファイル

  • 競合情勢
  • 戦略的展望
  • Thermo Fisher Scientific Inc.
  • Becton, Dickinson and Company
  • STEMCELL Technologies Inc.
  • Merck KGaA
  • Athersys, Inc.
  • Mesoblast Limited
  • Cynata Therapeutics Limited
  • Plus Therapeutics, Inc.
  • Biorestorative Therapies, Inc.
  • CELLAION SA
  • Sangamo Therapeutics, Inc.
  • Vericel Corporation

第17章 総論・提言

  • Visiongainからの総論
  • 市場参入企業への提言
図表

List of Tables

  • Table 1 Stem Cell Technologies and Applications Market Snapshot, 2023 & 2033 (US$ Million, AGR %)
  • Table 2 Stem Cell Technologies and Applications Market Forecast by Region, 2023-2033 (US$ Million, CAGR%): "V" Shaped Recovery
  • Table 3 Stem Cell Technologies and Applications Market Forecast by Region, 2023-2033 (US$ Million, CAGR%): "U" Shaped Recovery
  • Table 4 Stem Cell Technologies and Applications Market Forecast by Region, 2023-2033 (US$ Million, CAGR%): "W" Shaped Recovery
  • Table 5 Stem Cell Technologies and Applications Market Forecast by Region, 2023-2033 (US$ Million, CAGR%): "L" Shaped Recovery
  • Table 6 Stem Cell Technologies and Applications Market Forecast by Type, 2023-2033 (US$ Million, CAGR%)
  • Table 7 Allogeneic Stem Cell Therapy Segment Market Forecast by Region, 2023-2033 (US$ Million, CAGR%)
  • Table 8 Autologous Stem Cell Therapy Segment Market Forecast by Region, 2023-2033 (US$ Million, CAGR%)
  • Table 9 Stem Cell Technologies and Applications Market Forecast by Cell Source, 2023-2033 (US$ Million, CAGR%)
  • Table 10 Adipose Tissue-derived MSCs Segment Market Forecast by Region, 2023-2033 (US$ Million, CAGR%)
  • Table 11 Bone Marrow-derived MSCs Segment Market Forecast by Region, 2023-2033 (US$ Million, CAGR%)
  • Table 12 Placental/umbilical cord-derived MSCs Segment Market Forecast by Region, 2023-2033 (US$ Million, CAGR%)
  • Table 13 Stem Cell Technologies and Applications Market Forecast by Product, 2023-2033 (US$ Million, CAGR%)
  • Table 14 Adult Stem Cells Segment Market Forecast by Region, 2023-2033 (US$ Million, CAGR%)
  • Table 15 Human Embryonic Stem Cells Segment Market Forecast by Region, 2023-2033 (US$ Million, CAGR%)
  • Table 16 Induced Pluripotent Stem Cells Segment Market Forecast by Region, 2023-2033 (US$ Million, CAGR%)
  • Table 17 Very Small Embryonic Like Stem Cells Segment Market Forecast by Region, 2023-2033 (US$ Million, CAGR%)
  • Table 18 Stem Cell Technologies and Applications Market Forecast by Technology, 2023-2033 (US$ Million, CAGR%)
  • Table 19 Cell Acquisition Segment Market Forecast by Region, 2023-2033 (US$ Million, CAGR%)
  • Table 20 Cell Production Segment Market Forecast by Region, 2023-2033 (US$ Million, CAGR%)
  • Table 21 Cryopreservation Segment Market Forecast by Region, 2023-2033 (US$ Million, CAGR%)
  • Table 22 Expansion & Sub-culture Segment Market Forecast by Region, 2023-2033 (US$ Million, CAGR%)
  • Table 23 Other Technology Segment Market Forecast by Region, 2023-2033 (US$ Million, CAGR%)
  • Table 24 Stem Cell Technologies and Applications Market Forecast by Application, 2023-2033 (US$ Million, CAGR%)
  • Table 25 Cancer Segment Market Forecast by Region, 2023-2033 (US$ Million, CAGR%)
  • Table 26 Cardiovascular Diseases Segment Market Forecast by Region, 2023-2033 (US$ Million, AGR%, CAGR%)
  • Table 27 Neurological Disorders Segment Market Forecast by Region, 2023-2033 (US$ Million, CAGR%)
  • Table 28 Inflammatory & Autoimmune Diseases Segment Market Forecast by Region, 2023-2033 (US$ Million, CAGR%)
  • Table 29 Musculoskeletal Disorders Segment Market Forecast by Region, 2023-2033 (US$ Million, CAGR%)
  • Table 30 Other Application Segment Market Forecast by Region, 2023-2033 (US$ Million, CAGR%)
  • Table 31 Stem Cell Technologies and Applications Market Forecast by End-use, 2023-2033 (US$ Million, CAGR%)
  • Table 32 Pharmaceutical & Biotechnology Companies Segment Market Forecast by Region, 2023-2033 (US$ Million, CAGR%)
  • Table 33 Hospitals & Cell Banks Segment Market Forecast by Region, 2023-2033 (US$ Million, CAGR%)
  • Table 34 Academic & Research Institutes Segment Market Forecast by Region, 2023-2033 (US$ Million, CAGR%)
  • Table 35 Stem Cell Technologies and Applications Market Forecast by Region, 2023-2033 (US$ Million, AGR %)
  • Table 36 North America Stem Cell Technologies and Applications Market Forecast by Country, 2023-2033 (US$ Million, AGR %)
  • Table 37 North America Stem Cell Technologies and Applications Market Forecast by Type, 2023-2033 (US$ Million, AGR %)
  • Table 38 North America Stem Cell Technologies and Applications Market Forecast by Cell Source, 2023-2033 (US$ Million, AGR %)
  • Table 39 North America Stem Cell Technologies and Applications Market Forecast by Product, 2023-2033 (US$ Million, AGR %)
  • Table 40 North America Stem Cell Technologies and Applications Market Forecast by Technology, 2023-2033 (US$ Million, AGR %)
  • Table 41 North America Stem Cell Technologies and Applications Market Forecast by Application, 2023-2033 (US$ Million, AGR %)
  • Table 42 North America Stem Cell Technologies and Applications Market Forecast by End-use, 2023-2033 (US$ Million, AGR %)
  • Table 43 U.S. Stem Cell Technologies and Applications Market Forecast, 2023-2033 (US$ Million, AGR %)
  • Table 44 Canada Stem Cell Technologies and Applications Market Forecast, 2023-2033 (US$ Million, AGR %)
  • Table 45 Europe Stem Cell Technologies and Applications Market Forecast by Country, 2023-2033 (US$ Million, AGR %)
  • Table 46 Europe Stem Cell Technologies and Applications Market Forecast by Type, 2023-2033 (US$ Million, AGR %)
  • Table 47 Europe Stem Cell Technologies and Applications Market Forecast by Cell Source, 2023-2033 (US$ Million, AGR %)
  • Table 48 Europe Stem Cell Technologies and Applications Market Forecast by Product, 2023-2033 (US$ Million, AGR %)
  • Table 49 Europe Stem Cell Technologies and Applications Market Forecast by Technology, 2023-2033 (US$ Million, AGR %)
  • Table 50 Europe Stem Cell Technologies and Applications Market Forecast by Application, 2023-2033 (US$ Million, AGR %)
  • Table 51 Europe Stem Cell Technologies and Applications Market Forecast by End-use, 2023-2033 (US$ Million, AGR %)
  • Table 52 Germany Stem Cell Technologies and Applications Market Forecast, 2023-2033 (US$ Million, AGR %)
  • Table 53 UK Stem Cell Technologies and Applications Market Forecast, 2023-2033 (US$ Million, AGR %)
  • Table 54 France Stem Cell Technologies and Applications Market Forecast, 2023-2033 (US$ Million, AGR %)
  • Table 55 Italy Stem Cell Technologies and Applications Market Forecast, 2023-2033 (US$ Million, AGR %)
  • Table 56 Spain Stem Cell Technologies and Applications Market Forecast, 2023-2033 (US$ Million, AGR %)
  • Table 57 Rest of Europe Stem Cell Technologies and Applications Market Forecast, 2023-2033 (US$ Million, AGR %)
  • Table 58 Asia Pacific Stem Cell Technologies and Applications Market Forecast by Country, 2023-2033 (US$ Million, AGR %)
  • Table 59 Asia Pacific Stem Cell Technologies and Applications Market Forecast by Type, 2023-2033 (US$ Million, AGR %)
  • Table 60 Asia Pacific Stem Cell Technologies and Applications Market Forecast by Cell Source, 2023-2033 (US$ Million, AGR %)
  • Table 61 Asia Pacific Stem Cell Technologies and Applications Market Forecast by Product, 2023-2033 (US$ Million, AGR %)
  • Table 62 Asia Pacific Stem Cell Technologies and Applications Market Forecast by Technology, 2023-2033 (US$ Million, AGR %)
  • Table 63 Asia Pacific Stem Cell Technologies and Applications Market Forecast by Application, 2023-2033 (US$ Million, AGR %)
  • Table 64 Asia Pacific Stem Cell Technologies and Applications Market Forecast by End-use, 2023-2033 (US$ Million, AGR %)
  • Table 65 China Stem Cell Technologies and Applications Market Forecast, 2023-2033 (US$ Million, AGR %)
  • Table 66 Japan Stem Cell Technologies and Applications Market Forecast, 2023-2033 (US$ Million, AGR %)
  • Table 67 India Stem Cell Technologies and Applications Market Forecast, 2023-2033 (US$ Million, AGR %)
  • Table 68 Australia Stem Cell Technologies and Applications Market Forecast, 2023-2033 (US$ Million, AGR %)
  • Table 69 South Korea Stem Cell Technologies and Applications Market Forecast, 2023-2033 (US$ Million, AGR %)
  • Table 70 Rest of Asia Pacific Stem Cell Technologies and Applications Market Forecast, 2023-2033 (US$ Million, AGR %)
  • Table 71 Latin America Stem Cell Technologies and Applications Market Forecast by Country, 2023-2033 (US$ Million, AGR %)
  • Table 72 Latin America Stem Cell Technologies and Applications Market Forecast by Type, 2023-2033 (US$ Million, AGR %)
  • Table 73 Latin America Stem Cell Technologies and Applications Market Forecast by Cell Source, 2023-2033 (US$ Million, AGR %)
  • Table 74 Latin America Stem Cell Technologies and Applications Market Forecast by Product, 2023-2033 (US$ Million, AGR %)
  • Table 75 Latin America Stem Cell Technologies and Applications Market Forecast by Technology, 2023-2033 (US$ Million, AGR %)
  • Table 76 Latin America Stem Cell Technologies and Applications Market Forecast by Application, 2023-2033 (US$ Million, AGR %)
  • Table 77 Latin America Stem Cell Technologies and Applications Market Forecast by End-use, 2023-2033 (US$ Million, AGR %)
  • Table 78 Brazil Stem Cell Technologies and Applications Market Forecast, 2023-2033 (US$ Million, AGR %)
  • Table 79 Mexico Stem Cell Technologies and Applications Market Forecast, 2023-2033 (US$ Million, AGR %)
  • Table 80 Rest of Latin America Stem Cell Technologies and Applications Market Forecast, 2023-2033 (US$ Million, AGR %)
  • Table 81 MEA Stem Cell Technologies and Applications Market Forecast by Country, 2023-2033 (US$ Million, AGR %)
  • Table 82 MEA Stem Cell Technologies and Applications Market Forecast by Type, 2023-2033 (US$ Million, AGR %)
  • Table 83 MEA Stem Cell Technologies and Applications Market Forecast by Cell Source, 2023-2033 (US$ Million, AGR %)
  • Table 84 MEA Stem Cell Technologies and Applications Market Forecast by Product, 2023-2033 (US$ Million, AGR %)
  • Table 85 MEA Stem Cell Technologies and Applications Market Forecast by Technology, 2023-2033 (US$ Million, AGR %)
  • Table 86 MEA Stem Cell Technologies and Applications Market Forecast by Application, 2023-2033 (US$ Million, AGR %)
  • Table 87 MEA Stem Cell Technologies and Applications Market Forecast by End-use, 2023-2033 (US$ Million, AGR %)
  • Table 88 South Africa Stem Cell Technologies and Applications Market Forecast, 2023-2033 (US$ Million, AGR %)
  • Table 89 GCC Stem Cell Technologies and Applications Market Forecast, 2023-2033 (US$ Million, AGR %)
  • Table 90 Rest of MEA Stem Cell Technologies and Applications Market Forecast, 2023-2033 (US$ Million, AGR %)
  • Table 91 Strategic Outlook
  • Table 92 Thermo Fisher Scientific Inc.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 93 Thermo Fisher Scientific Inc.: Product Benchmarking
  • Table 94 Thermo Fisher Scientific Inc.: Strategic Outlook
  • Table 95 Becton, Dickinson and Company: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 96 Becton, Dickinson and Company.: Product Benchmarking
  • Table 97 Becton, Dickinson and Company.: Strategic Outlook
  • Table 98 STEMCELL Technologies Inc.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 99 STEMCELL Technologies Inc.: Product Benchmarking
  • Table 100 Merck KGaA: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 101 Merck KGaA.: Product Benchmarking
  • Table 102 Athersys, Inc.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 103 Athersys, Inc.: Product Benchmarking
  • Table 104 Athersys, Inc.: Strategic Outlook
  • Table 105 Mesoblast Limited: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 106 Mesoblast Limited: Product Benchmarking
  • Table 107 Cynata Therapeutics Limited: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 108 Cynata Therapeutics Limited: Product Benchmarking
  • Table 109 Plus Therapeutics, Inc.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 110 Plus Therapeutics, Inc.: Product Benchmarking
  • Table 111 Plus Therapeutics, Inc.: Strategic Outlook
  • Table 112 Biorestorative Therapies, Inc.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 113 Biorestorative Therapies, Inc.: Product Benchmarking
  • Table 114 Cellaion SA: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 115 CELLAION SA: Product Benchmarking
  • Table 116 Sangamo Therapeutics, Inc.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 117 SANGAMO THERAPEUTICS, INC.: Product Benchmarking
  • Table 118 Vericel Corporation: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 119 VERICEL CORPORATION: Product Benchmarking
  •  

List of Figures

  • Figure 1 Stem Cell Technologies and Applications Market Segmentation
  • Figure 2 Stem Cell Technologies and Applications Market by Product: Market Attractiveness Index
  • Figure 3 Stem Cell Technologies and Applications Market by Cell Source: Market Attractiveness Index
  • Figure 4 Stem Cell Technologies and Applications Market by Type: Market Attractiveness Index
  • Figure 5 Stem Cell Technologies and Applications Market by Technology: Market Attractiveness Index
  • Figure 6 Stem Cell Technologies and Applications Market by Application: Market Attractiveness Index
  • Figure 7 Stem Cell Technologies and Applications Market by End-use: Market Attractiveness Index
  • Figure 8 Stem Cell Technologies and Applications Market Attractiveness Index by Region
  • Figure 9 Stem Cell Technologies and Applications Market: Market Dynamics
  • Figure 10 Stem Cell Technologies and Applications Market by Region, 2023-2033 (US$ Million, AGR %): "V" Shaped Recovery
  • Figure 11 Stem Cell Technologies and Applications Market by Region, 2023-2033 (US$ Million, AGR %): "U" Shaped Recovery
  • Figure 12 Stem Cell Technologies and Applications Market by Region, 2023-2033 (US$ Million, AGR %): "W" Shaped Recovery
  • Figure 13 Stem Cell Technologies and Applications Market by Region, 2023-2033 (US$ Million, AGR %): "L" Shaped Recovery
  • Figure 14 PEST Analysis of Stem Cell Technologies and Applications Market
  • Figure 15 Stem Cell Technologies and Applications Market by Type: Market Attractiveness Index
  • Figure 16 Stem Cell Technologies and Applications Market Forecast by Type, 2023-2033 (US$ Million, AGR %)
  • Figure 17 Stem Cell Technologies and Applications Market Share Forecast by Type, 2023, 2028, 2033 (%)
  • Figure 18 Allogeneic Stem Cell Therapy Segment Market Forecast by Region, 2023-2033 (US$ Million, AGR %)
  • Figure 19 Allogeneic Stem Cell Therapy Segment Market Share Forecast by Region, 2023 & 2033 (%)
  • Figure 20 Autologous Stem Cell Therapy Segment Market Forecast by Region, 2023-2033 (US$ Million, AGR %)
  • Figure 21 Autologous Stem Cell Therapy Segment Market Share Forecast by Region, 2023 & 2033 (%)
  • Figure 22 Stem Cell Technologies and Applications Market by Cell Source: Market Attractiveness Index
  • Figure 23 Stem Cell Technologies and Applications Market Forecast by Cell Source, 2023-2033 (US$ Million, AGR %)
  • Figure 24 Stem Cell Technologies and Applications Market Share Forecast by Cell Source, 2023, 2028, 2033 (%)
  • Figure 25 Adipose Tissue-derived MSCs Segment Market Forecast by Region, 2023-2033 (US$ Million, AGR %)
  • Figure 26 Adipose Tissue-derived MSCs Segment Market Share Forecast by Region, 2023 & 2033 (%)
  • Figure 27 Bone Marrow-derived MSCs Segment Market Forecast by Region, 2023-2033 (US$ Million, AGR %)
  • Figure 28 Bone Marrow-derived MSCs Segment Market Share Forecast by Region, 2023 & 2033 (%)
  • Figure 29 Placental/umbilical cord-derived MSCs Segment Market Forecast by Region, 2023-2033 (US$ Million, AGR %)
  • Figure 30 Placental/umbilical cord-derived MSCs Segment Market Share Forecast by Region, 2023 & 2033 (%)
  • Figure 31 Stem Cell Technologies and Applications Market by Product: Market Attractiveness Index
  • Figure 32 Stem Cell Technologies and Applications Market Forecast by Product, 2023-2033 (US$ Million, AGR %)
  • Figure 33 Stem Cell Technologies and Applications Market Share Forecast by Product, 2023, 2028, 2033 (%)
  • Figure 34 Adult Stem Cells Segment Market Forecast by Region, 2023-2033 (US$ Million, AGR %)
  • Figure 35 Adult Stem Cells Segment Market Share Forecast by Region, 2023 & 2033 (%)
  • Figure 36 Human Embryonic Stem Cells Segment Market Forecast by Region, 2023-2033 (US$ Million, AGR %)
  • Figure 37 Human Embryonic Stem Cells Segment Market Share Forecast by Region, 2023 & 2033 (%)
  • Figure 38 Induced Pluripotent Stem Cells Segment Market Forecast by Region, 2023-2033 (US$ Million, AGR %)
  • Figure 39 Induced Pluripotent Stem Cells Segment Market Share Forecast by Region, 2023 & 2033 (%)
  • Figure 40 Very Small Embryonic Like Stem Cells Segment Market Forecast by Region, 2023-2033 (US$ Million, AGR %)
  • Figure 41 Very Small Embryonic Like Stem Cells Segment Market Share Forecast by Region, 2023 & 2033 (%)
  • Figure 42 Stem Cell Technologies and Applications Market by Technology: Market Attractiveness Index
  • Figure 43 Stem Cell Technologies and Applications Market Forecast by Technology, 2023-2033 (US$ Million, AGR %)
  • Figure 44 Stem Cell Technologies and Applications Market Share Forecast by Technology, 2023, 2028, 2033 (%)
  • Figure 45 Cell Acquisition Segment Market Forecast by Region, 2023-2033 (US$ Million, AGR %)
  • Figure 46 Cell Acquisition Segment Market Share Forecast by Region, 2023 & 2033 (%)
  • Figure 47 Cell Production Segment Market Forecast by Region, 2023-2033 (US$ Million, AGR %)
  • Figure 48 Cell Production Segment Market Share Forecast by Region, 2023 & 2033 (%)
  • Figure 49 Cryopreservation Segment Market Forecast by Region, 2023-2033 (US$ Million, AGR %)
  • Figure 50 Cryopreservation Segment Market Share Forecast by Region, 2023 & 2033 (%)
  • Figure 51 Expansion & Sub-culture Segment Market Forecast by Region, 2023-2033 (US$ Million, AGR %)
  • Figure 52 Expansion & Sub-culture Segment Market Share Forecast by Region, 2023 & 2033 (%)
  • Figure 53 Other Technology Segment Market Forecast by Region, 2023-2033 (US$ Million, AGR %)
  • Figure 54 Other Technology Segment Market Share Forecast by Region, 2023 & 2033 (%)
  • Figure 55 Stem Cell Technologies and Applications Market by Application: Market Attractiveness Index
  • Figure 56 Stem Cell Technologies and Applications Market Forecast by Application, 2023-2033 (US$ Million, AGR %)
  • Figure 57 Stem Cell Technologies and Applications Market Share Forecast by Application, 2023, 2028, 2033 (%)
  • Figure 58 Cancer Segment Market Forecast by Region, 2023-2033 (US$ Million, AGR %)
  • Figure 59 Cancer Segment Market Share Forecast by Region, 2023 & 2033 (%)
  • Figure 60 Cardiovascular Diseases Segment Market Forecast by Region, 2023-2033 (US$ Million, AGR %)
  • Figure 61 Cardiovascular Diseases Segment Market Share Forecast by Region, 2023 & 2033 (%)
  • Figure 62 Neurological Disorders Segment Market Forecast by Region, 2023-2033 (US$ Million, AGR %)
  • Figure 63 Neurological Disorders Segment Market Share Forecast by Region, 2023 & 2033 (%)
  • Figure 64 Inflammatory & Autoimmune Diseases Segment Market Forecast by Region, 2023-2033 (US$ Million, AGR %)
  • Figure 65 Inflammatory & Autoimmune Diseases Segment Market Share Forecast by Region, 2023 & 2033 (%)
  • Figure 66 Musculoskeletal Disorders Segment Market Forecast by Region, 2023-2033 (US$ Million, AGR %)
  • Figure 67 Musculoskeletal Disorders Segment Market Share Forecast by Region, 2023 & 2033 (%)
  • Figure 68 Other Application Segment Market Forecast by Region, 2023-2033 (US$ Million, AGR %)
  • Figure 69 Other Application Segment Market Share Forecast by Region, 2023 & 2033 (%)
  • Figure 70 Stem Cell Technologies and Applications Market by End-use: Market Attractiveness Index
  • Figure 71 Stem Cell Technologies and Applications Market Forecast by End-use, 2023-2033 (US$ Million, AGR %)
  • Figure 72 Stem Cell Technologies and Applications Market Share Forecast by End-use, 2023, 2028, 2033 (%)
  • Figure 73 Pharmaceutical & Biotechnology Companies Segment Market Forecast by Region, 2023-2033 (US$ Million, AGR %)
  • Figure 74 Pharmaceutical & Biotechnology Companies Segment Market Share Forecast by Region, 2023 & 2033 (%)
  • Figure 75 Hospitals & Cell Banks Segment Market Forecast by Region, 2023-2033 (US$ Million, AGR %)
  • Figure 76 Hospitals & Cell Banks Segment Market Share Forecast by Region, 2023 & 2033 (%)
  • Figure 77 Academic & Research Institutes Segment Market Forecast by Region, 2023-2033 (US$ Million, AGR %)
  • Figure 78 Academic & Research Institutes Segment Market Share Forecast by Region, 2023 & 2033 (%)
  • Figure 79 Stem Cell Technologies and Applications Market Forecast by Region 2023 and 2033 (Revenue, CAGR%)
  • Figure 80 Stem Cell Technologies and Applications Market Share Forecast by Region 2023, 2028, 2033 (%)
  • Figure 81 Stem Cell Technologies and Applications Market by Region, 2023-2033 (US$ Million, AGR %)
  • Figure 82 North America Stem Cell Technologies and Applications Market Attractiveness Index
  • Figure 83 North America Stem Cell Technologies and Applications Market by Region, 2023, 2028 & 2033 (US$ Million)
  • Figure 84 North America Stem Cell Technologies and Applications Market Forecast by Country, 2023-2033 (US$ Million, AGR %)
  • Figure 85 North America Stem Cell Technologies and Applications Market Share Forecast by Country, 2023 & 2033 (%)
  • Figure 86 North America Stem Cell Technologies and Applications Market Forecast by Type, 2023-2033 (US$ Million, AGR %)
  • Figure 87 North America Stem Cell Technologies and Applications Market Share Forecast by Type, 2023 & 2033 (%)
  • Figure 88 North America Stem Cell Technologies and Applications Market Forecast by Cell Source, 2023-2033 (US$ Million, AGR %)
  • Figure 89 North America Stem Cell Technologies and Applications Market Share Forecast by Cell Source, 2023 & 2033 (%)
  • Figure 90 North America Stem Cell Technologies and Applications Market Forecast by Product, 2023-2033 (US$ Million, AGR %)
  • Figure 91 North America Stem Cell Technologies and Applications Market Share Forecast by Product, 2023 & 2033 (%)
  • Figure 92 North America Stem Cell Technologies and Applications Market Forecast by Technology, 2023-2033 (US$ Million, AGR %)
  • Figure 93 North America Stem Cell Technologies and Applications Market Share Forecast by Technology, 2023 & 2033 (%)
  • Figure 94 North America Stem Cell Technologies and Applications Market Forecast by Application, 2023-2033 (US$ Million, AGR %)
  • Figure 95 North America Stem Cell Technologies and Applications Market Share Forecast by Application, 2023 & 2033 (%)
  • Figure 96 North America Stem Cell Technologies and Applications Market Forecast by End-use, 2023-2033 (US$ Million, AGR %)
  • Figure 97 North America Stem Cell Technologies and Applications Market Share Forecast by End-use, 2023 & 2033 (%)
  • Figure 98 U.S. Stem Cell Technologies and Applications Market Forecast, 2023-2033 (US$ Million, AGR %)
  • Figure 99 Canada Stem Cell Technologies and Applications Market Forecast, 2023-2033 (US$ Million, AGR %)
  • Figure 100 Europe Stem Cell Technologies and Applications Market Attractiveness Index
  • Figure 101 Europe Stem Cell Technologies and Applications Market by Region, 2023, 2028 & 2033 (US$ Million)
  • Figure 102 Europe Stem Cell Technologies and Applications Market Forecast by Country, 2023-2033 (US$ Million, AGR %)
  • Figure 103 Europe Stem Cell Technologies and Applications Market Share Forecast by Country, 2023 & 2033 (%)
  • Figure 104 Europe Stem Cell Technologies and Applications Market Forecast by Type, 2023-2033 (US$ Million, AGR %)
  • Figure 105 Europe Stem Cell Technologies and Applications Market Share Forecast by Type, 2023 & 2033 (%)
  • Figure 106 Europe Stem Cell Technologies and Applications Market Forecast by Cell Source, 2023-2033 (US$ Million, AGR %)
  • Figure 107 Europe Stem Cell Technologies and Applications Market Share Forecast by Cell Source, 2023 & 2033 (%)
  • Figure 108 Europe Stem Cell Technologies and Applications Market Forecast by Product, 2023-2033 (US$ Million, AGR %)
  • Figure 109 Europe Stem Cell Technologies and Applications Market Share Forecast by Product, 2023 & 2033 (%)
  • Figure 110 Europe Stem Cell Technologies and Applications Market Forecast by Technology, 2023-2033 (US$ Million, AGR %)
  • Figure 111 Europe Stem Cell Technologies and Applications Market Share Forecast by Technology, 2023 & 2033 (%)
  • Figure 112 Europe Stem Cell Technologies and Applications Market Forecast by Application, 2023-2033 (US$ Million, AGR %)
  • Figure 113 Europe Stem Cell Technologies and Applications Market Share Forecast by Application, 2023 & 2033 (%)
  • Figure 114 Europe Stem Cell Technologies and Applications Market Forecast by End-use, 2023-2033 (US$ Million, AGR %)
  • Figure 115 Europe Stem Cell Technologies and Applications Market Share Forecast by End-use, 2023 & 2033 (%)
  • Figure 116 Germany Stem Cell Technologies and Applications Market Forecast, 2023-2033 (US$ Million, AGR %)
  • Figure 117 UK Stem Cell Technologies and Applications Market Forecast, 2023-2033 (US$ Million, AGR %)
  • Figure 118 France Stem Cell Technologies and Applications Market Forecast, 2023-2033 (US$ Million, AGR %)
  • Figure 119 Italy Stem Cell Technologies and Applications Market Forecast, 2023-2033 (US$ Million, AGR %)
  • Figure 120 Spain Stem Cell Technologies and Applications Market Forecast, 2023-2033 (US$ Million, AGR %)
  • Figure 121 Rest of Europe Stem Cell Technologies and Applications Market Forecast, 2023-2033 (US$ Million, AGR %)
  • Figure 122 Asia Pacific Stem Cell Technologies and Applications Market Attractiveness Index
  • Figure 123 Asia Pacific Stem Cell Technologies and Applications Market by Region, 2023, 2028 & 2033 (US$ Million)
  • Figure 124 Asia Pacific Stem Cell Technologies and Applications Market Forecast by Country, 2023-2033 (US$ Million, AGR %)
  • Figure 125 Asia Pacific Stem Cell Technologies and Applications Market Share Forecast by Country, 2023 & 2033 (%)
  • Figure 126 Asia Pacific Stem Cell Technologies and Applications Market Forecast by Type, 2023-2033 (US$ Million, AGR %)
  • Figure 127 Asia Pacific Stem Cell Technologies and Applications Market Share Forecast by Type, 2023 & 2033 (%)
  • Figure 128 Asia Pacific Stem Cell Technologies and Applications Market Forecast by Cell Source, 2023-2033 (US$ Million, AGR %)
  • Figure 129 Asia Pacific Stem Cell Technologies and Applications Market Share Forecast by Cell Source, 2023 & 2033 (%)
  • Figure 130 Asia Pacific Stem Cell Technologies and Applications Market Forecast by Product, 2023-2033 (US$ Million, AGR %)
  • Figure 131 Asia Pacific Stem Cell Technologies and Applications Market Share Forecast by Product, 2023 & 2033 (%)
  • Figure 132 Asia Pacific Stem Cell Technologies and Applications Market Forecast by Technology, 2023-2033 (US$ Million, AGR %)
  • Figure 133 Asia Pacific Stem Cell Technologies and Applications Market Share Forecast by Technology, 2023 & 2033 (%)
  • Figure 134 Asia Pacific Stem Cell Technologies and Applications Market Forecast by Application, 2023-2033 (US$ Million, AGR %)
  • Figure 135 Asia Pacific Stem Cell Technologies and Applications Market Share Forecast by Application, 2023 & 2033 (%)
  • Figure 136 Asia Pacific Stem Cell Technologies and Applications Market Forecast by End-use, 2023-2033 (US$ Million, AGR %)
  • Figure 137 Asia Pacific Stem Cell Technologies and Applications Market Share Forecast by End-use, 2023 & 2033 (%)
  • Figure 138 China Stem Cell Technologies and Applications Market Forecast, 2023-2033 (US$ Million, AGR %)
  • Figure 139 Japan Stem Cell Technologies and Applications Market Forecast, 2023-2033 (US$ Million, AGR %)
  • Figure 140 India Stem Cell Technologies and Applications Market Forecast, 2023-2033 (US$ Million, AGR %)
  • Figure 141 Australia Stem Cell Technologies and Applications Market Forecast, 2023-2033 (US$ Million, AGR %)
  • Figure 142 South Korea Stem Cell Technologies and Applications Market Forecast, 2023-2033 (US$ Million, AGR %)
  • Figure 143 Rest of Asia Pacific Stem Cell Technologies and Applications Market Forecast, 2023-2033 (US$ Million, AGR %)
  • Figure 144 Latin America Stem Cell Technologies and Applications Market Attractiveness Index
  • Figure 145 Latin America Stem Cell Technologies and Applications Market by Region, 2023, 2028 & 2033 (US$ Million)
  • Figure 146 Latin America Stem Cell Technologies and Applications Market Forecast by Country, 2023-2033 (US$ Million, AGR %)
  • Figure 147 Latin America Stem Cell Technologies and Applications Market Share Forecast by Country, 2023 & 2033 (%)
  • Figure 148 Latin America Stem Cell Technologies and Applications Market Forecast by Type, 2023-2033 (US$ Million, AGR %)
  • Figure 149 Latin America Stem Cell Technologies and Applications Market Share Forecast by Type, 2023 & 2033 (%)
  • Figure 150 Latin America Stem Cell Technologies and Applications Market Forecast by Cell Source, 2023-2033 (US$ Million, AGR %)
  • Figure 151 Latin America Stem Cell Technologies and Applications Market Share Forecast by Cell Source, 2023 & 2033 (%)
  • Figure 152 Latin America Stem Cell Technologies and Applications Market Forecast by Product, 2023-2033 (US$ Million, AGR %)
  • Figure 153 Latin America Stem Cell Technologies and Applications Market Share Forecast by Product, 2023 & 2033 (%)
  • Figure 154 Latin America Stem Cell Technologies and Applications Market Forecast by Technology, 2023-2033 (US$ Million, AGR %)
  • Figure 155 Latin America Stem Cell Technologies and Applications Market Share Forecast by Technology, 2023 & 2033 (%)
  • Figure 156 Latin America Stem Cell Technologies and Applications Market Forecast by Application, 2023-2033 (US$ Million, AGR %)
  • Figure 157 Latin America Stem Cell Technologies and Applications Market Share Forecast by Application, 2023 & 2033 (%)
  • Figure 158 Latin America Stem Cell Technologies and Applications Market Forecast by End-use, 2023-2033 (US$ Million, AGR %)
  • Figure 159 Latin America Stem Cell Technologies and Applications Market Share Forecast by End-use, 2023 & 2033 (%)
  • Figure 160 Brazil Stem Cell Technologies and Applications Market Forecast, 2023-2033 (US$ Million, AGR %)
  • Figure 161 Mexico Stem Cell Technologies and Applications Market Forecast, 2023-2033 (US$ Million, AGR %)
  • Figure 162 Rest of Latin America Stem Cell Technologies and Applications Market Forecast, 2023-2033 (US$ Million, AGR %)
  • Figure 163 MEA Stem Cell Technologies and Applications Market Attractiveness Index
  • Figure 164 MEA Stem Cell Technologies and Applications Market by Region, 2023, 2028 & 2033 (US$ Million)
  • Figure 165 MEA Stem Cell Technologies and Applications Market Forecast by Country, 2023-2033 (US$ Million, AGR %)
  • Figure 166 MEA Stem Cell Technologies and Applications Market Share Forecast by Country, 2023 & 2033 (%)
  • Figure 167 MEA Stem Cell Technologies and Applications Market Forecast by Type, 2023-2033 (US$ Million, AGR %)
  • Figure 168 MEA Stem Cell Technologies and Applications Market Share Forecast by Type, 2023 & 2033 (%)
  • Figure 169 MEA Stem Cell Technologies and Applications Market Forecast by Cell Source, 2023-2033 (US$ Million, AGR %)
  • Figure 170 MEA Stem Cell Technologies and Applications Market Share Forecast by Cell Source, 2023 & 2033 (%)
  • Figure 171 MEA Stem Cell Technologies and Applications Market Forecast by Product, 2023-2033 (US$ Million, AGR %)
  • Figure 172 MEA Stem Cell Technologies and Applications Market Share Forecast by Product, 2023 & 2033 (%)
  • Figure 173 MEA Stem Cell Technologies and Applications Market Forecast by Technology, 2023-2033 (US$ Million, AGR %)
  • Figure 174 MEA Stem Cell Technologies and Applications Market Share Forecast by Technology, 2023 & 2033 (%)
  • Figure 175 MEA Stem Cell Technologies and Applications Market Forecast by Application, 2023-2033 (US$ Million, AGR %)
  • Figure 176 MEA Stem Cell Technologies and Applications Market Share Forecast by Application, 2023 & 2033 (%)
  • Figure 177 MEA Stem Cell Technologies and Applications Market Forecast by End-use, 2023-2033 (US$ Million, AGR %)
  • Figure 178 MEA Stem Cell Technologies and Applications Market Share Forecast by End-use, 2023 & 2033 (%)
  • Figure 179 South Africa Stem Cell Technologies and Applications Market Forecast, 2023-2033 (US$ Million, AGR %)
  • Figure 180 GCC Stem Cell Technologies and Applications Market Forecast, 2023-2033 (US$ Million, AGR %)
  • Figure 181 Rest of MEA Stem Cell Technologies and Applications Market Forecast, 2023-2033 (US$ Million, AGR %)
  • Figure 182 Stem Cell Technologies and Applications Market: Company Share/Ranking, 2022
  • Figure 183 Thermo Fisher Scientific Inc.: Net Revenue, 2017-2022 (US$ Million, AGR%)
  • Figure 184 Thermo Fisher Scientific Inc.: R&D, 2017-2022 (US$ Million, AGR%)
  • Figure 185 Thermo Fisher Scientific Inc.: Regional Market Shares, 2022
  • Figure 186 Becton, Dickinson and Company: Net Revenue, 2017-2022 (US$ Million, AGR%)
  • Figure 187 Becton, Dickinson and Company.: R&D, 2017-2022 (US$ Million, AGR%)
  • Figure 188 Becton, Dickinson and Company.: Regional Market Shares, 2022
  • Figure 189 Merck KGaA: Net Revenue, 2017-2022 (US$ Million, AGR%)
  • Figure 190 Merck KGaA.: R&D, 2017-2022 (US$ Million, AGR%)
  • Figure 191 Merck KGaA.: Regional Market Shares, 2022
  • Figure 192 Athersys, Inc.: Net Revenue, 2017-2022 (US$ Million, AGR%)
  • Figure 193 Athersys,
目次
Product Code: PHA1293

The global Stem Cell Technologies and Applications market is projected to grow at a CAGR of 8.7% by 2033.

“The Stem Cell Technologies and Applications Market Report 2023-2033”: This report will prove invaluable to leading firms striving for new revenue pockets if they wish to understand the industry and its underlying dynamics better. It will be useful for companies that want to expand into different industries or their existing operations in a new region.

Growing Government Support Driving Market Growth

Growing government support for stem cell research and development is fuelling the growth of stem cell companies. In 2022, we saw a number of significant developments in this area. Global governments are making significant investments in stem cell research. For instance, the US National Institutes of Health (NIH) funded stem cell research with $3.7 billion in 2022. New programmes are being introduced by governments to assist stem cell companies. In 2022, for instance, the UK government established a new fund worth £30 million ($37 million) to assist stem cell firms in introducing novel therapies to the market.

Furthermore, there is a developing trend in the industry. This indicates that investors' interest in this industry is rising. Verve Therapeutics, a stem cell firm, raised $100 million at its first public offering (IPO) in 2022.

The following are a few specific advances in stem cell companies that happened in 2022:

  • Clinical studies for stem cell therapies: In 2022, several stem cell therapies were introduced into clinical trials. For instance, a Phase 3 clinical trial for the stem cell therapy for sickle cell disease was started by Bluebird Bio
  • Regulatory clearances for stem cell companies: In 2022, a number of stem cell companies were granted regulatory approvals. For instance, Kite Pharma, a stem cell business, was approved by the FDA to use stem cells to treat non-Hodgkin lymphoma.

These are but a handful of the numerous advancements that the stem cell sector saw in 2022. This rise is mostly due to the growing support from the government, which is expected to encourage the creation of new stem cell medicines as well as the expansion of stem cell companies in the years to come.

High Cost of Stem Cell Therapies to Hamper Industry Growth

A variety of illnesses and disorders may be treated or made better with the help of stem cell therapy, a cutting-edge medical innovation. The high expense of stem cell therapy is one of the main obstacles, though. Depending on the type of stem cells utilised, the ailment being treated, and the location of the treatment centre, the average cost of stem cell therapy today ranges from $5,000 to $50,000.

The high price of stem cell therapy is caused by a variety of variables. The price of creating and developing stem cell therapies is one of the factors. The production of stem cell therapies is difficult and demands a high level of knowledge and technology. The expense of stem cell therapies is further increased by the fact that they are frequently customised for each patient.

The absence of insurance coverage is another reason that raises the price of stem cell therapy. Due to the fact that stem cell therapy is currently regarded as an experimental procedure, the majority of insurance companies do not cover it. This implies that patients frequently bear the financial burden of covering the entire expense of treatment.

What Questions Should You Ask Before Buying a Market Research Report?

  • How is the stem cell technologies and applications market evolving?
  • What is driving and restraining stem cell technologies and applications market?
  • How will each stem cell technologies and applications submarket segment grow over the forecast period, and how much revenue will these submarkets account for in 2033?
  • How will the market shares for each stem cell technologies and applications submarket develop from 2023 to 2033?
  • What will be the main driver for the overall market from 2023 to 2033?
  • Will leading stem cell technologies and applications markets broadly follow the macroeconomic dynamics, or will individual national markets outperform others?
  • How will the market shares of the national markets change by 2033, and which geographical region will lead the market in 2033?
  • Who are the leading players, and what are their prospects over the forecast period?
  • What are the stem cell technologies and applications projects for these leading companies?
  • How will the industry evolve during the period between 2023 and 2033? What are the implications of stem cell technologies and applications projects taking place now and over the next 10 years?
  • Is there a greater need for product commercialization to further scale stem cell technologies and applications market?
  • Where is the stem cell technologies and applications market heading and how can you ensure you are at the forefront of the market?
  • What are the best investment options for new product and service lines?
  • What are the key prospects for moving companies into a new growth path and C-suite?

You need to discover how this will impact the stem cell technologies and applications market today, and over the next 10 years:

  • Our 337-page report provides 119 tables and 198 charts/graphs exclusively to you
  • The report highlights key lucrative areas in the industry so you can target them - NOW
  • It contains in-depth analysis of global, regional and national sales and growth
  • It highlights for you the key successful trends, changes and revenue projections made by your competitors.

This report tells you TODAY how the stem cell technologies and applications market will develop in the next 10 years, and in line with the variations in COVID-19 economic recession and bounce. This market is more critical now than at any point over the last 10 years.

Forecasts to 2033 and other analyses reveal commercial prospects

  • In addition to revenue forecasting to 2033, our new study provides you with recent results, growth rates, and market shares
  • You will find original analyses, with business outlooks and developments
  • Discover qualitative analyses (including market dynamics, drivers, opportunities, restraints and challenges), cost structure, impact of rising stem cell technologies and applications prices and recent developments.

This report includes data analysis and invaluable insight into how COVID-19 will affect the industry and your company. Four COVID-19 recovery patterns and their impact, namely, ""V" ", "L", "W" and "U" are discussed in this report.

Segments Covered in the Report:

Type Outlook

  • Allogeneic Stem Cell Therapy
  • Autologous Stem Cell Therapy

Cell Source

  • Adipose Tissue-derived MSCs
  • Bone Marrow-derived MSCs
  • Placental/Umbilical Cord-derived MSCs

Product

  • Adult Stem Cells
  • Human Embryonic Stem Cells
  • Induced Pluripotent Stem Cells
  • Very Small Embryonic Like Stem Cells

Technology

  • Cell Acquisition
  • Cell Production
  • Cryopreservation
  • Expansion & Sub-culture
  • Other Technology

Application

  • Cancer
  • Cardiovascular Diseases
  • Neurological Disorders
  • Inflammatory & Autoimmune Diseases
  • Musculoskeletal Disorders
  • Other Applications

End-Use

  • Pharmaceutical & Biotechnology Companies
  • Hospitals & Cell Banks
  • Academic & Research Institutes

In addition to the revenue predictions for the overall world market and segments, you will also find revenue forecasts for five regional and the U.S., China, U.K., India, and Brazil leading national markets:

North America

  • U.S
  • Canada

Europe

  • Germany
  • UK
  • France
  • Spain
  • Italy
  • Rest of Europe

Asia Pacific

  • China
  • Japan
  • India
  • Australia
  • South Korea
  • Rest of Asia Pacific

Latin America

  • Brazil
  • Mexico
  • Rest of Latin America

MEA

  • GCC
  • South Africa
  • Rest of MEA

The report also includes profiles and for some of the leading companies in the Stem Cell Technologies and Applications Market, 2023 to 2033, with a focus on this segment of these companies' operations.

Leading Companies and the Potential for market growth:

  • Athersys, Inc.
  • Becton, Dickinson and Company
  • Biorestorative Therapies, Inc
  • CELLAION SA
  • Cynata Therapeutics Limited
  • Merck KGaA
  • Mesoblast Limited
  • Plus Therapeutics, Inc
  • Sangamo Therapeutics, Inc
  • STEMCELL Technologies Inc
  • Thermo Fisher Scientific Inc
  • Vericel Corporation

Overall world revenue for Stem Cell Technologies and Applications Market, 2023 to 2033 in terms of value the market will surpass US$10,000.0 million in 2023, our work calculates. We predict strong revenue growth through to 2033. Our work identifies which organizations hold the greatest potential. Discover their capabilities, progress, and commercial prospects, helping you stay ahead.

How will the “Stem Cell Technologies and Applications Market, 2023 to 2033” report help you?

In summary, our 330+ page report provides you with the following knowledge:

  • Revenue forecasts to 2033 for Stem Cell Technologies and Applications Market, 2023 to 2033 Market, with forecasts for type, cell source, product, technology, application, and end use each forecast at a global and regional level - discover the industry's prospects, finding the most lucrative places for investments and revenues.
  • Revenue forecasts to 2033 for five regional and 20 key national markets - See forecasts for the Stem Cell Technologies and Applications Market, 2023 to 2033 market in North America, Europe, Asia-Pacific, Latin America, and MEA. Also forecasted is the market in the US, Canada, Mexico, Brazil, Germany, France, UK, Italy, China, India, Japan, and Australia among other prominent economies.
  • Prospects for established firms and those seeking to enter the market - including company profiles for Thermo Fisher Scientific Inc., Becton, Dickinson and Company, STEMCELL Technologies Inc., Merck KGaA of the major companies involved in the Stem Cell Technologies and Applications Market, 2023 to 2033.

Find quantitative and qualitative analyses with independent predictions. Receive information that only our report contains, staying informed with invaluable business intelligence.

Information found nowhere else

With our new report, you are less likely to fall behind in knowledge or miss out on opportunities. See how our work could benefit your research, analyses, and decisions. Our study is for everybody needing commercial analyses for the Stem Cell Technologies and Applications Market, 2023 to 2033, market-leading companies. You will find data, trends and predictions.

Table of Contents

1 Report Overview

  • 1.1 Objectives of the Study
  • 1.2 Introduction to Stem Cell Technologies and Applications Market
  • 1.3 What This Report Delivers
  • 1.4 Why You Should Read This Report
  • 1.5 Key Questions Answered by This Analytical Report
  • 1.6 Who is This Report for?
  • 1.7 Methodology
    • 1.7.1 Market Definitions
    • 1.7.2 Market Evaluation & Forecasting Methodology
    • 1.7.3 Data Validation
      • 1.7.3.1 Primary Research
      • 1.7.3.2 Secondary Research
  • 1.8 Frequently Asked Questions (FAQs)
  • 1.9 Associated Visiongain Reports
  • 1.10 About Visiongain

2 Executive Summary

3 Market Overview

  • 3.1 Key Findings
  • 3.2 Market Dynamics
    • 3.2.1 Market Driving Factors
      • 3.2.1.1 Rising Awareness About Stem Cell Therapies
      • 3.2.1.2 Government Support for Stem Cell Research
      • 3.2.1.3 Increasing Number of Clinical Trials
    • 3.2.2 Market Restraining Factors
      • 3.2.2.1 High Cost of Stem Cell Therapies
      • 3.2.2.2 Lack of Regulatory Clarity
    • 3.2.3 Market Opportunities
      • 3.2.3.1 Increasing Investment in Stem Cell Research and Development
  • 3.3 COVID-19 Impact Analysis
  • 3.4 Porter Analysis
  • 3.5 PEST Analysis

4 Stem Cell Technologies and Applications Market Analysis by Type

  • 4.1 Key Findings
  • 4.2 Type Segment: Market Attractiveness Index
  • 4.3 Stem Cell Technologies and Applications Market Size Estimation and Forecast by Type
  • 4.4 Allogeneic Stem Cell Therapy
    • 4.4.1 Market Size by Region, 2023-2033 (US$ Million)
    • 4.4.2 Market Share by Region, 2023 & 2033 (%)
  • 4.5 Autologous Stem Cell Therapy
    • 4.5.1 Market Size by Region, 2023-2033 (US$ Million)
    • 4.5.2 Market Share by Region, 2023 & 2033 (%)

5 Stem Cell Technologies and Applications Market Analysis by Cell Source

  • 5.1 Key Findings
  • 5.2 Cell Source Segment: Market Attractiveness Index
  • 5.3 Stem Cell Technologies and Applications Market Size Estimation and Forecast by Cell Source
  • 5.4 Adipose tissue-derived MSCs
    • 5.4.1 Market Size by Region, 2023-2033 (US$ Million)
    • 5.4.2 Market Share by Region, 2023 & 2033 (%)
  • 5.5 Bone marrow-derived MSCs
    • 5.5.1 Market Size by Region, 2023-2033 (US$ Million)
    • 5.5.2 Market Share by Region, 2023 & 2033 (%)
  • 5.6 Placental/umbilical cord-derived MSCs
    • 5.6.1 Market Size by Region, 2023-2033 (US$ Million)
    • 5.6.2 Market Share by Region, 2023 & 2033 (%)

6 Stem Cell Technologies and Applications Market Analysis by Product

  • 6.1 Key Findings
  • 6.2 Product Segment: Market Attractiveness Index
  • 6.3 Stem Cell Technologies and Applications Market Size Estimation and Forecast by Product
  • 6.4 Adult Stem Cells
    • 6.4.1 Market Size by Region, 2023-2033 (US$ Million)
    • 6.4.2 Market Share by Region, 2023 & 2033 (%)
  • 6.5 Human Embryonic Stem Cells
    • 6.5.1 Market Size by Region, 2023-2033 (US$ Million)
    • 6.5.2 Market Share by Region, 2023 & 2033 (%)
  • 6.6 Induced Pluripotent Stem Cells
    • 6.6.1 Market Size by Region, 2023-2033 (US$ Million)
    • 6.6.2 Market Share by Region, 2023 & 2033 (%)
  • 6.7 Very Small Embryonic Like Stem Cells
    • 6.7.1 Market Size by Region, 2023-2033 (US$ Million)
    • 6.7.2 Market Share by Region, 2023 & 2033 (%)

7 Stem Cell Technologies and Applications Market Analysis by Technology

  • 7.1 Key Findings
  • 7.2 Technology Segment: Market Attractiveness Index
  • 7.3 Stem Cell Technologies and Applications Market Size Estimation and Forecast by Technology
  • 7.4 Cell Acquisition
    • 7.4.1 Market Size by Region, 2023-2033 (US$ Million)
    • 7.4.2 Market Share by Region, 2023 & 2033 (%)
  • 7.5 Cell Production
    • 7.5.1 Market Size by Region, 2023-2033 (US$ Million)
    • 7.5.2 Market Share by Region, 2023 & 2033 (%)
  • 7.6 Cryopreservation
    • 7.6.1 Market Size by Region, 2023-2033 (US$ Million)
    • 7.6.2 Market Share by Region, 2023 & 2033 (%)
  • 7.7 Expansion & Sub-Culture
    • 7.7.1 Market Size by Region, 2023-2033 (US$ Million)
    • 7.7.2 Market Share by Region, 2023 & 2033 (%)
  • 7.8 Other Technology
    • 7.8.1 Market Size by Region, 2023-2033 (US$ Million)
    • 7.8.2 Market Share by Region, 2023 & 2033 (%)

8 Stem Cell Technologies and Applications Market Analysis by Application

  • 8.1 Key Findings
  • 8.2 Application Segment: Market Attractiveness Index
  • 8.3 Stem Cell Technologies and Applications Market Size Estimation and Forecast by Application
  • 8.4 Cancer
    • 8.4.1 Market Size by Region, 2023-2033 (US$ Million)
    • 8.4.2 Market Share by Region, 2023 & 2033 (%)
  • 8.5 Cardiovascular Diseases
    • 8.5.1 Market Size by Region, 2023-2033 (US$ Million)
    • 8.5.2 Market Share by Region, 2023 & 2033 (%)
  • 8.6 Neurological Disorders
    • 8.6.1 Market Size by Region, 2023-2033 (US$ Million)
    • 8.6.2 Market Share by Region, 2023 & 2033 (%)
  • 8.7 Inflammatory & Autoimmune Diseases
    • 8.7.1 Market Size by Region, 2023-2033 (US$ Million)
    • 8.7.2 Market Share by Region, 2023 & 2033 (%)
  • 8.8 Musculoskeletal Disorders
    • 8.8.1 Market Size by Region, 2023-2033 (US$ Million)
    • 8.8.2 Market Share by Region, 2023 & 2033 (%)
  • 8.9 Other Application
    • 8.9.1 Market Size by Region, 2023-2033 (US$ Million)
    • 8.9.2 Market Share by Region, 2023 & 2033 (%)

9 Stem Cell Technologies and Applications Market Analysis by End-use

  • 9.1 Key Findings
  • 9.2 End-use Segment: Market Attractiveness Index
  • 9.3 Stem Cell Technologies and Applications Market Size Estimation and Forecast by End-use
  • 9.4 Pharmaceutical & Biotechnology Companies
    • 9.4.1 Market Size by Region, 2023-2033 (US$ Million)
    • 9.4.2 Market Share by Region, 2023 & 2033 (%)
  • 9.5 Hospitals & Cell Banks
    • 9.5.1 Market Size by Region, 2023-2033 (US$ Million)
    • 9.5.2 Market Share by Region, 2023 & 2033 (%)
  • 9.6 Academic & Research Institutes
    • 9.6.1 Market Size by Region, 2023-2033 (US$ Million)
    • 9.6.2 Market Share by Region, 2023 & 2033 (%)

10 Stem Cell Technologies and Applications Market Analysis by Region

  • 10.1 Key Findings
  • 10.2 Regional Market Size Estimation and Forecast

11 North America Stem Cell Technologies and Applications Market Analysis

  • 11.1 Key Findings
  • 11.2 North America Stem Cell Technologies and Applications Market Attractiveness Index
  • 11.3 North America Stem Cell Technologies and Applications Market by Country, 2023, 2028 & 2033 (US$ Million)
  • 11.4 North America Stem Cell Technologies and Applications Market Size Estimation and Forecast by Country
  • 11.5 North America Stem Cell Technologies and Applications Market Size Estimation and Forecast by Type
  • 11.6 North America Stem Cell Technologies and Applications Market Size Estimation and Forecast by Cell Source
  • 11.7 North America Stem Cell Technologies and Applications Market Size Estimation and Forecast by Product
  • 11.8 North America Stem Cell Technologies and Applications Market Size Estimation and Forecast by Technology
  • 11.9 North America Stem Cell Technologies and Applications Market Size Estimation and Forecast by Application
  • 11.10 North America Stem Cell Technologies and Applications Market Size Estimation and Forecast by End-use
  • 11.11 U.S. Stem Cell Technologies and Applications Market Analysis
  • 11.12 Canada Stem Cell Technologies and Applications Market Analysis

12 Europe Stem Cell Technologies and Applications Market Analysis

  • 12.1 Key Findings
  • 12.2 Europe Stem Cell Technologies and Applications Market Attractiveness Index
  • 12.3 Europe Stem Cell Technologies and Applications Market by Country, 2023, 2028 & 2033 (US$ Million)
  • 12.4 Europe Stem Cell Technologies and Applications Market Size Estimation and Forecast by Country
  • 12.5 Europe Stem Cell Technologies and Applications Market Size Estimation and Forecast by Type
  • 12.6 Europe Stem Cell Technologies and Applications Market Size Estimation and Forecast by Cell Source
  • 12.7 Europe Stem Cell Technologies and Applications Market Size Estimation and Forecast by Product
  • 12.8 Europe Stem Cell Technologies and Applications Market Size Estimation and Forecast by Technology
  • 12.9 Europe Stem Cell Technologies and Applications Market Size Estimation and Forecast by Application
  • 12.10 Europe Stem Cell Technologies and Applications Market Size Estimation and Forecast by End-use
  • 12.11 Germany Stem Cell Technologies and Applications Market Analysis
  • 12.12 UK Stem Cell Technologies and Applications Market Analysis
  • 12.13 France Stem Cell Technologies and Applications Market Analysis
  • 12.14 Italy Stem Cell Technologies and Applications Market Analysis
  • 12.15 Spain Stem Cell Technologies and Applications Market Analysis
  • 12.16 Rest of Europe Stem Cell Technologies and Applications Market Analysis

13 Asia-Pacific Stem Cell Technologies and Applications Market Analysis

  • 13.1 Key Findings
  • 13.2 Asia-Pacific Stem Cell Technologies and Applications Market Attractiveness Index
  • 13.3 Asia-Pacific Stem Cell Technologies and Applications Market by Country, 2023, 2028 & 2033 (US$ Million)
  • 13.4 Asia-Pacific Stem Cell Technologies and Applications Market Size Estimation and Forecast by Country
  • 13.5 Asia Pacific Stem Cell Technologies and Applications Market Size Estimation and Forecast by Type
  • 13.6 Asia Pacific Stem Cell Technologies and Applications Market Size Estimation and Forecast by Cell Source
  • 13.7 Asia Pacific Stem Cell Technologies and Applications Market Size Estimation and Forecast by Product
  • 13.8 Asia Pacific Stem Cell Technologies and Applications Market Size Estimation and Forecast by Technology
  • 13.9 Asia Pacific Stem Cell Technologies and Applications Market Size Estimation and Forecast by Application
  • 13.10 Asia Pacific Stem Cell Technologies and Applications Market Size Estimation and Forecast by End-use
  • 13.11 China Stem Cell Technologies and Applications Market Analysis
  • 13.12 Japan Stem Cell Technologies and Applications Market Analysis
  • 13.13 India Stem Cell Technologies and Applications Market Analysis
  • 13.14 Australia Stem Cell Technologies and Applications Market Analysis
  • 13.15 South Korea Stem Cell Technologies and Applications Market Analysis
  • 13.16 Rest of Asia-Pacific Stem Cell Technologies and Applications Market Analysis

14 Latin America Stem Cell Technologies and Applications Market Analysis

  • 14.1 Key Findings
  • 14.2 Latin America Stem Cell Technologies and Applications Market Attractiveness Index
  • 14.3 Latin America Stem Cell Technologies and Applications Market by Country, 2023, 2028 & 2033 (US$ Million)
  • 14.4 Latin America Stem Cell Technologies and Applications Market Size Estimation and Forecast by Country
  • 14.5 Latin America Stem Cell Technologies and Applications Market Size Estimation and Forecast by Type
  • 14.6 Latin America Stem Cell Technologies and Applications Market Size Estimation and Forecast by Cell Source
  • 14.7 Latin America Stem Cell Technologies and Applications Market Size Estimation and Forecast by Product
  • 14.8 Latin America Stem Cell Technologies and Applications Market Size Estimation and Forecast by Technology
  • 14.9 Latin America Stem Cell Technologies and Applications Market Size Estimation and Forecast by Application
  • 14.10 Latin America Stem Cell Technologies and Applications Market Size Estimation and Forecast by End-use
  • 14.11 Brazil Stem Cell Technologies and Applications Market Analysis
  • 14.12 Mexico Stem Cell Technologies and Applications Market Analysis
  • 14.13 Rest of Latin America Stem Cell Technologies and Applications Market Analysis

15 MEA Stem Cell Technologies and Applications Market Analysis

  • 15.1 Key Findings
  • 15.2 MEA Stem Cell Technologies and Applications Market Attractiveness Index
  • 15.3 MEA Stem Cell Technologies and Applications Market by Country, 2023, 2028 & 2033 (US$ Million)
  • 15.4 MEA Stem Cell Technologies and Applications Market Size Estimation and Forecast by Country
  • 15.5 MEA Stem Cell Technologies and Applications Market Size Estimation and Forecast by Type
  • 15.6 MEA Stem Cell Technologies and Applications Market Size Estimation and Forecast by Cell Source
  • 15.7 MEA Stem Cell Technologies and Applications Market Size Estimation and Forecast by Product
  • 15.8 MEA Stem Cell Technologies and Applications Market Size Estimation and Forecast by Technology
  • 15.9 MEA Stem Cell Technologies and Applications Market Size Estimation and Forecast by Application
  • 15.10 MEA Stem Cell Technologies and Applications Market Size Estimation and Forecast by End-use
  • 15.11 South Africa Stem Cell Technologies and Applications Market Analysis
  • 15.12 GCC Stem Cell Technologies and Applications Market Analysis
  • 15.13 Rest of MEA Stem Cell Technologies and Applications Market Analysis

16 Company Profiles

  • 16.1 Competitive Landscape, 2022
  • 16.2 Strategic Outlook
  • 16.3 Thermo Fisher Scientific Inc.
    • 16.3.1 Company Snapshot
    • 16.3.2 Company Overview
    • 16.3.3 Financial Analysis
      • 16.3.3.1 Net Revenue, 2017-2022
      • 16.3.3.2 R&D, 2017-2022
      • 16.3.3.3 Regional Market Shares, 2022
    • 16.3.4 Product Benchmarking
    • 16.3.5 Strategic Outlook
  • 16.4 Becton, Dickinson and Company
    • 16.4.1 Company Snapshot
    • 16.4.2 Company Overview
    • 16.4.3 Financial Analysis
      • 16.4.3.1 Net Revenue, 2017-2022
      • 16.4.3.2 R&D, 2017-2022
      • 16.4.3.3 Regional Market Shares, 2022
    • 16.4.4 Product Benchmarking
    • 16.4.5 Strategic Outlook
  • 16.5 STEMCELL Technologies Inc.
    • 16.5.1 Company Snapshot
    • 16.5.2 Company Overview
    • 16.5.3 Product Benchmarking
  • 16.6 Merck KGaA
    • 16.6.1 Company Snapshot
    • 16.6.2 Company Overview
    • 16.6.3 Financial Analysis
      • 16.6.3.1 Net Revenue, 2017-2022
      • 16.6.3.2 R&D, 2017-2022
      • 16.6.3.3 Regional Market Shares, 2022
    • 16.6.4 Product Benchmarking
  • 16.7 Athersys, Inc.
    • 16.7.1 Company Snapshot
    • 16.7.2 Company Overview
    • 16.7.3 Financial Analysis
      • 16.7.3.1 Net Revenue, 2017-2022
      • 16.7.3.2 R&D, 2017-2022
    • 16.7.4 Product Benchmarking
    • 16.7.5 Strategic Outlook
  • 16.8 Mesoblast Limited
    • 16.8.1 Company Snapshot
    • 16.8.2 Company Overview
    • 16.8.3 Product Benchmarking
  • 16.9 Cynata Therapeutics Limited
    • 16.9.1 Company Snapshot
    • 16.9.2 Company Overview
    • 16.9.3 Financial Analysis
      • 16.9.3.1 Net Revenue, 2017-2022
    • 16.9.4 Product Benchmarking
  • 16.10 Plus Therapeutics, Inc.
    • 16.10.1 Company Snapshot
    • 16.10.2 Company Overview
    • 16.10.3 Product Benchmarking
    • 16.10.4 Strategic Outlook
  • 16.11 Biorestorative Therapies, Inc.
    • 16.11.1 Company Snapshot
    • 16.11.2 Company Overview
    • 16.11.3 Product Benchmarking
  • 16.12 CELLAION SA
    • 16.12.1 Company Snapshot
    • 16.12.2 Company Overview
    • 16.12.3 Product Benchmarking
  • 16.13 Sangamo Therapeutics, Inc.
    • 16.13.1 Company Snapshot
    • 16.13.2 Company Overview
    • 16.13.3 Financial Analysis
      • 16.13.3.1 Net Revenue, 2017-2022
      • 16.13.3.2 R&D, 2017-2022
    • 16.13.4 Product Benchmarking
  • 16.14 Vericel Corporation
    • 16.14.1 Company Snapshot
    • 16.14.2 Company Overview
    • 16.14.3 Financial Analysis
      • 16.14.3.1 Net Revenue, 2017-2022
      • 16.14.3.2 R&D, 2017-2022
    • 16.14.4 Product Benchmarking

17 Conclusion and Recommendations

  • 17.1 Concluding Remarks from Visiongain
  • 17.2 Recommendations for Market Players